Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Berger

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
Orphanet Journal of Rare Diseases|August 27, 2016
Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issuesChristian J Hendriksz, Kenneth I Berger, Christina Lampe, et al.
Journal of Inherited Metabolic Disease|February 24, 2012
Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVAChristian J Hendriksz, Maisoon Al-Jawad, Kenneth I Berger, et al.
Chest|April 3, 2007
World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workersGabriel Izbicki, Robert Chavko, Gisela I Banauch, et al.
Journal of Neuromuscular Diseases|December 31, 2023
Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase AlfaMatthias Boentert, Emmanuelle Salort Campana, Shahram Attarian, et al.
Obesity (Silver Spring, Md.)|August 11, 2006
Effect of circulatory congestion on the components of pulmonary diffusing capacity in morbid obesityBeno W Oppenheimer, Kenneth I Berger, Douglas A Rennert, et al.
Chest|September 25, 2007
Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposureBeno W Oppenheimer, Roberta M Goldring, Matthew E Herberg, et al.
Environmental Health Perspectives|April 7, 2005
The World Trade Center residents' respiratory health study: new-onset respiratory symptoms and pulmonary functionJoan Reibman, Shao Lin, Syni-An A Hwang, et al.
Orphanet Journal of Rare Diseases|January 12, 2024
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe diseaseMatthias Boentert, Kenneth I Berger, Jordi Díaz-Manera, et al.
Journal of Neuromuscular Diseases|May 21, 2025
Defining clinically meaningful thresholds for forced vital capacity in patients with neuromuscular disorders: Lessons learned from the COMET study in Pompe diseaseKenneth I Berger, Cristina Ivanescu, Jérôme Msihid, et al.
Chest|February 4, 2021
Validation of a Novel Compact System for the Measurement of Lung VolumesKenneth I Berger, Ori Adam, Roberto Walter Dal Negro, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Orphanet Journal of Rare Diseases|August 27, 2016
Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issuesChristian J Hendriksz, Kenneth I Berger, Christina Lampe, et al.
Journal of Inherited Metabolic Disease|February 24, 2012
Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVAChristian J Hendriksz, Maisoon Al-Jawad, Kenneth I Berger, et al.
Chest|April 3, 2007
World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workersGabriel Izbicki, Robert Chavko, Gisela I Banauch, et al.
Journal of Neuromuscular Diseases|December 31, 2023
Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase AlfaMatthias Boentert, Emmanuelle Salort Campana, Shahram Attarian, et al.
Obesity (Silver Spring, Md.)|August 11, 2006
Effect of circulatory congestion on the components of pulmonary diffusing capacity in morbid obesityBeno W Oppenheimer, Kenneth I Berger, Douglas A Rennert, et al.
Chest|September 25, 2007
Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposureBeno W Oppenheimer, Roberta M Goldring, Matthew E Herberg, et al.
Environmental Health Perspectives|April 7, 2005
The World Trade Center residents' respiratory health study: new-onset respiratory symptoms and pulmonary functionJoan Reibman, Shao Lin, Syni-An A Hwang, et al.
Orphanet Journal of Rare Diseases|January 12, 2024
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe diseaseMatthias Boentert, Kenneth I Berger, Jordi Díaz-Manera, et al.
Journal of Neuromuscular Diseases|May 21, 2025
Defining clinically meaningful thresholds for forced vital capacity in patients with neuromuscular disorders: Lessons learned from the COMET study in Pompe diseaseKenneth I Berger, Cristina Ivanescu, Jérôme Msihid, et al.
Chest|February 4, 2021
Validation of a Novel Compact System for the Measurement of Lung VolumesKenneth I Berger, Ori Adam, Roberto Walter Dal Negro, et al.
Pageof 11